8 Aug 2019 - The Global Live Cell
Imaging Market is subject to
witness a substantial growth due to the increasing occurrence of chronic
diseases and growing demand for advanced diagnostic facilities. Other factors
such as accelerated drug discovery & research and development of advanced
diagnostic techniques contribute to the growth of market in both developed and
developing economies across the globe.
Additionally,
growing popularity of kinetic research instead of fixed cellular analysis is
predicted to drive the market expansion during the forecast period. Globally,
the market is predicted to grow at significant CAGR in the forecast period,
providing numerous opportunities for market players to invest in research and
development in the live cell imaging market.
Growth
in investment in the research & development of efficient live cell imaging
methodologies is also anticipated to fuel the growth of the market in the
upcoming years. Furthermore, recent investment made by healthcare organizations
such as Health Connexions, National Institute of Health, and W.M. Keck
Foundation for research & development in various imaging methodologies that
are widely adopted in the sectors such as healthcare, food & beverages, and
environment sciences, are estimated to amplify market value of live cell
imaging in the near future.
Increasing
collaboration among private players and various research institutes &
universities to produce innovative products and co-develop advanced imaging
techniques are expected to drive market growth in the years to come. For
instance, Northeastern University of Boston and Phase Holographic Imaging are
recently co-developing Holo-Monitor technology to manufacture a unique solution
for cell analysis. In addition, rise in the number of mergers, acquisitions and
partnerships by industry players in order to strengthen their market position
in the live cell imaging industry and generate additional revenue are expected
to fuel market growth in the upcoming years as well.
The
market is broadly categorized into three major types on the basis of products
such as equipment, consumable, and software used in live cell imaging.
Equipment is considered as one of the fastest growing segment in the market
with the substantial revenue generation in the last couple of years. Growing
popularity of the equipment segment in attributed to the development of the
innovative products and extensive research in the field. The equipment market
segment is divided into microscopes, cell analyzers, image capturing systems,
and standalone systems. The consumable market segment has also witnessed
substantial market growth over the forecast period.
Recent
technological advancement in the healthcare sector has led to development of
the imaging cell technology for spatial resolutions within a time range.
Consumables market segment is increasingly playing vital role for optimization
of the yielded results. Additionally, enhanced optimal dye, probes, and medium
are considered as critical for time-lapse imaging, in which the cells are
exposed for a longer duration of time. However, potency of cells might
negatively affect with wrong choice of medium.
The
market is divided by region as North America, Europe, Asia-Pacific, Latin
America and Africa. North America has shown major growth in recent years owing
to the rise in the adoption of latest technologies, increase in the healthcare
expenditure by local governments in the region, rise in the per capita income
among general population, and existence of well-established healthcare
infrastructure.
European
region is predicted to hold major market share in the live cell imaging market
with massive growth in forecast period. Countries such as France, U.K. and
Germany are leading the European market with rising geriatric population,
growing demands for intensive research in chronic diseases such as cancer,
neurodegeneration and cardiac diseases, and significant investment by leading
industry players considering potential growth opportunities in the region.
The
key players in the live cell imaging market are Carl Zeiss Meditec AG, Leica
Microsystems GmbH, Nikon Co., Becton, Dickinson and Company, GE Healthcare,
Olympus Co., Thermo Fisher Scientific Incorporations, Sigma-Aldrich Co.,
PerkinElmer Incorporations, and Molecular Devices Ltd.
Comments
Post a Comment